1. United States of America Stocks

  2. •

    Healthcare

  3. •

    Biotechnology
Kyverna Therapeutics, Inc.

Kyverna Therapeutics, Inc.

KYTX
Kyverna Therapeutics, Inc.US flagNASDAQ
9.91
USD
+0.23
- -
433.98MMarket Cap

Income Statement (USD)

APIChatGPT
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
As of date
12/31/2021
12/31/2022
12/31/2023
12/31/2024
12/31/2025
Sales/Revenue/Turnover
6
7
- -
- -
- -
+ Sales & Services Revenue
6
7
- -
- -
- -
- Cost of Revenue
- -
- -
- -
- -
- -
+ Cost of Goods & Services
- -
- -
- -
- -
- -
Gross Profit
- -
- -
- -
- -
- -
+ Other Operating Income
-6
-7
- -
- -
- -
- Operating Expenses
32
36
62
143
170
+ Selling, General & Admin
6
8
12
30
36
+ Research & Development
26
28
50
112
134
+ Other Operating Expense
- -
- -
- -
- -
- -
Operating Income (Loss)
-26
-29
-62
-143
-170
- Non-Operating (Income) Loss
- -
- -
-2
-15
-9
+ Interest Expense, Net
- -
- -
-2
-15
-9
+ Interest Expense
- -
- -
- -
- -
- -
- Interest Income
- -
1
2
15
9
+ Other Non-Op (Income) Loss
- -
- -
- -
- -
- -
Pretax Income
-26
-29
-60
-127
-161
- Income Tax Expense (Benefit)
- -
- -
- -
- -
- -
- (Income) Loss from Affiliates
- -
- -
- -
- -
- -
Income (Loss) from Cont Ops
-26
-29
-60
-127
-161
- Net Extraordinary Losses (Gains)
- -
- -
- -
- -
- -
+ Discontinued Operations
- -
- -
- -
- -
- -
+ Extraord. & Accounting Changes
- -
- -
- -
- -
- -
Income (Loss) Incl. MI
-26
-29
-60
-127
-161
- Minority Interest
- -
- -
- -
- -
- -
Net Income, GAAP
-26
-29
-60
-127
-161
- Preferred Dividends
- -
- -
- -
- -
- -
- Other Adjustments
- -
- -
- -
- -
- -
Net Income Avail to Common, GAAP
-26
-29
-60
-127
-161
EBIT
-26
-29
-62
-143
-170
EBITDA
-26
-28
-61
-140
-168
EBITDA Margin (%)
-455.45
-403.32
- -
- -
- -
EBITA
-26
-29
-62
-143
-170
Gross Margin (%)
100
100
- -
- -
- -
Operating Margin (%)
-465.81
-418.28
- -
- -
- -
Profit Margin (%)
-465.88
-411.29
- -
- -
- -
Sales per Employee
- -
- -
- -
- -
- -
Dividend per Share
- -
- -
- -
- -
- -
Depreciation Expense
1
1
2
2
2
Basic Weighted Avg Shares
26
26
41
38
44
Basic EPS, GAAP
-1.02
-1.12
-1.48
-3.33
-3.64
Basic EPS from Cont Ops
-1.02
-1.12
-1.48
-3.33
-3.64
Diluted Weighted Avg Shares
26
26
41
38
44
Diluted EPS, GAAP
-1.02
-1.12
-1.48
-3.33
-3.64
Diluted EPS from Cont Ops
-1.02
-1.12
-1.48
-3.33
-3.64

Balance Sheet (USD)

APIChatGPT
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
As of date
12/31/2021
12/31/2022
12/31/2023
12/31/2024
12/31/2025
Total Current Assets
77
53
61
291
283
+ Cash, Cash Equivalents & STI
76
51
58
286
279
+ Cash & Cash Equivalents
76
38
35
97
124
+ ST Investments
- -
14
23
189
155
+ Accounts & Notes Receiv
- -
- -
- -
- -
- -
+ Accounts Receivable, Net
- -
- -
- -
- -
- -
+ Notes Receivable, Net
- -
- -
- -
- -
- -
+ Loans Receivable, Net
- -
- -
- -
- -
- -
+ Other Receivable, Net
- -
- -
- -
- -
- -
+ Inventories
- -
- -
- -
- -
- -
+ Raw Materials
- -
- -
- -
- -
- -
+ Work In Process
- -
- -
- -
- -
- -
+ Finished Goods
- -
- -
- -
- -
- -
+ Inventory Adjustments
- -
- -
- -
- -
- -
+ Other Inventory
- -
- -
- -
- -
- -
+ Other ST Assets
1
2
3
5
4
+ Misc ST Assets
- -
- -
- -
- -
- -
+ Prepaid Expenses
- -
- -
- -
- -
- -
+ ST Derivative & Hedging Assets
- -
- -
- -
- -
- -
+ ST Assets Held-for-Sale
- -
- -
- -
- -
- -
+ ST Deferred Tax Assets
- -
- -
- -
- -
- -
Total Noncurrent Assets
8
14
15
14
11
+ Property, Plant & Equip, Net
8
12
11
11
5
+ Property, Plant & Equip
9
14
13
14
9
- Accumulated Depreciation
1
2
2
4
4
+ LT Investments & Receivables
- -
- -
- -
- -
- -
+ LT Investments
- -
- -
- -
- -
- -
+ LT Receivables
- -
- -
- -
- -
- -
+ Other LT Assets
1
1
4
3
5
+ Total Intangible Assets
- -
- -
- -
- -
- -
+ Goodwill
- -
- -
- -
- -
- -
+ Other Intangible Assets
- -
- -
- -
- -
- -
+ LT Deferred Tax Assets
- -
- -
- -
- -
- -
+ LT Derivative & Hedging Assets
- -
- -
- -
- -
- -
+ Misc LT Assets
1
1
4
3
5
Total Assets
85
67
75
305
294
+ Payables & Accruals
7
8
14
25
23
+ Accounts Payable
1
1
4
5
5
+ Accrued Taxes
- -
- -
- -
- -
- -
+ Interest & Dividends Payable
- -
- -
- -
- -
- -
+ Other Payables & Accruals
7
6
10
20
17
+ ST Debt
1
2
3
4
4
+ ST Borrowings
- -
- -
- -
- -
- -
+ ST Finance Leases
1
2
3
4
4
+ Other ST Liabilities
8
2
3
5
10
+ Deferred Revenue
6
- -
- -
- -
- -
+ Derivatives & Hedging
- -
- -
- -
- -
- -
+ Deferred Tax Liabilities
- -
- -
- -
- -
- -
+ Misc ST Liabilities
2
2
3
5
10
Total Current Liabilities
16
12
20
34
36
+ LT Debt
5
8
6
4
25
+ LT Borrowings
- -
- -
- -
- -
25
+ LT Finance Leases
5
8
6
4
- -
+ Other LT Liabilities
111
121
181
- -
- -
+ Accrued Liabilities
1
- -
- -
- -
- -
+ Pension Liabilities
- -
- -
- -
- -
- -
+ Deferred Revenue
- -
- -
- -
- -
- -
+ Deferred Tax Liabilities
- -
- -
- -
- -
- -
+ Derivatives & Hedging
- -
- -
- -
- -
- -
+ Misc LT Liabilities
110
121
181
- -
- -
Total Noncurrent Liabilities
116
129
187
4
25
Total Liabilities
132
141
207
38
62
+ Preferred Equity and Hybrid Capital
- -
- -
- -
- -
- -
+ Share Capital & APIC
1
2
5
530
657
+ Common Stock
- -
- -
- -
- -
- -
+ Additional Paid in Capital
1
2
5
530
657
- Treasury Stock
- -
- -
- -
- -
- -
+ Retained Earnings
-47
-76
-136
-264
-425
+ Other Equity
- -
- -
- -
- -
- -
Equity Before Minority Interest
-46
-74
-131
267
232
+ Minority/Non Controlling Interest
- -
- -
- -
- -
- -
Total Equity
-46
-74
-131
267
232
Total Liabilities & Equity
85
67
75
305
294
Shares Outstanding
41
41
43
43
60
Number of Employees
- -
- -
- -
- -
- -
Capital Leases - Total
6
11
9
8
4
Net Debt
-76
-38
-35
-97
-99
Net Debt to Equity
164.45
51
26.37
-36.24
-42.77
Tangible Common Equity Ratio
-54.11
-110.57
-174.74
87.51
79.05
Current Ratio
4.84
4.45
3.05
8.61
7.75
Cash Conversion Cycle
- -
- -
- -
- -
- -

Cash Flow Statement (USD)

APIChatGPT
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
As of date
12/31/2021
12/31/2022
12/31/2023
12/31/2024
12/31/2025
+ Net Income
-26
-29
-60
-127
-161
+ Depreciation & Amortization
1
1
2
2
2
+ Non-Cash Items
8
2
3
3
7
+ Stock-Based Compensation
7
1
2
8
10
+ Deferred Income Taxes
- -
- -
- -
- -
- -
+ Asset Impairment Charge
- -
- -
- -
- -
1
+ Other Non-Cash Adj
1
1
1
-5
-4
+ Chg in Non-Cash Work Cap
-4
-10
3
8
-1
+ (Inc) Dec in Accts Receiv
- -
- -
- -
- -
- -
+ (Inc) Dec in Inventories
- -
- -
- -
- -
- -
+ (Inc) Dec in Prepaid Assets
-1
-1
-1
-2
1
+ Inc (Dec) in Accts Payable
2
-1
8
14
2
+ Inc (Dec) in Other
-6
-9
-4
-4
-4
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
Cash from Operating Activities
-22
-36
-52
-114
-154
+ Change in Fixed & Intang
- -
- -
- -
- -
- -
+ Disp in Fixed & Intang
- -
- -
- -
- -
- -
+ Disp of Fixed Prod Assets
- -
- -
- -
- -
- -
+ Disp of Intangible Assets
- -
- -
- -
- -
- -
+ Acq of Fixed & Intang
-1
-1
-1
-2
- -
+ Acq of Fixed Prod Assets
-1
-1
-1
-2
- -
+ Acq of Intangible Assets
- -
- -
- -
- -
- -
+ Cash (Repurchase) of Equity
- -
- -
- -
341
116
+ Increase in Capital Stock
- -
- -
- -
341
116
+ Decrease in Capital Stock
- -
- -
- -
- -
- -
+ Net Change in LT Investment
- -
-13
-8
-159
41
+ Dec in LT Investment
- -
43
47
331
406
+ Inc in LT Investment
- -
-56
-55
-490
-365
+ Net Cash From Acq & Div
- -
- -
- -
- -
- -
+ Cash from Divestitures
- -
- -
- -
- -
- -
+ Cash for Acq of Subs
- -
- -
- -
- -
- -
+ Cash for JVs
- -
- -
- -
- -
- -
+ Other Investing Activities
- -
- -
- -
- -
-1
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
Cash from Investing Activities
-1
-14
-9
-161
40
+ Dividends Paid
- -
- -
- -
- -
- -
+ Net Cash From Debt
- -
- -
-1
-1
-1
+ Cash From Debt
- -
- -
- -
- -
- -
+ Repayments of Debt
- -
- -
-1
-1
-1
+ Other Financing Activities
73
12
59
-3
26
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
Cash from Financing Activities
73
12
58
337
141
Effect of Foreign Exchange Rates
- -
- -
- -
- -
- -
Net Changes in Cash
49
-38
-3
62
27
EBITDA
-26
-28
-61
-140
-168
EBITDA Margin (%)
-455.45
-403.32
- -
- -
- -
Free Cash Flow
-23
-37
-53
-116
-154
Net Cash Paid for Acquisitions
- -
- -
- -
- -
- -
Free Cash Flow to Firm
- -
- -
- -
- -
- -
Free Cash Flow to Equity
- -
-37
-54
-117
-154
Free Cash Flow per Basic Share
-0.91
-1.43
-1.3
-3.04
-3.47
Price/Free Cash Flow
- -
- -
- -
-1.28
-2.71
Cash Flow to Net Income
0.84
1.25
0.87
0.9
0.95
Capital Expenditures
-1
-1
-1
-2
- -